NEWSROOM

Pharmaceutical

Odyssey Health, Inc. Announces Positive Results from Its Phase I Multi-Day Ascending Dosing for the Treatment of Concussion

  Las Vegas, NV, August 10, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-improving medical products, today announces the completion and safety findings from Cohort I of its Multi-Day Ascending Dosing (MAD) arm for its Phase I Clinical Trial. Odyssey’s trial is administering PRV-002, its novel drug to treat concussion, to healthy human subjects. MAD Cohort I subjects were dosed for five...

read more

Odyssey Health, Inc. Launches New Corporate Website

  Las Vegas, NV, August 04, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, is pleased to announce the launch of its new innovative corporate website: https://www.odysseyhealthinc.com/. The new corporate website, like the Company’s previously announced name change, was designed to not only better reflect Odyssey Health’s mission and focus, but also improve communication...

read more

Odyssey Health, Inc. Successfully Completes Phase I Single Ascending Dosing for Intranasal Concussion Drug

  Las Vegas, NV, July 12, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-enhancing medical products, today announced the completion of all three cohorts in their Phase I Single Ascending Dosing (SAD) clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. For SAD, the drug was safe and well tolerated. Concussions...

read more

Odyssey Health, Inc. Completes Safety Evaluation of Cohort II for Concussion Drug

  Las Vegas, NV, June 29, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, today announced positive safety findings from Cohort II of their Phase I clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. Data from Cohort II indicates that the drug was safe and well-tolerated. The trial is...

read more

RedChip Interviews Odyssey Health, Inc.’s CEO Michael Redmond

  Las Vegas, NV, June 08, 2022 -- McapMediaWire -- RedChip Companies will air a new C-Level interview with Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International on The RedChip Money Report® on Bloomberg TV, this Saturday, June 11, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the US. RedChip’s CEO Dave Gentry interviews Odyssey’s CEO Michael Redmond in this exclusive interview, covering the questions on the mind of...

read more

Odyssey Health, Inc. Completes Safety Evaluation of Cohort I for Concussion Drug

  IRVINE, CA, June 01, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, today announced positive safety findings from Cohort I of their Phase I clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. For Cohort I, the drug was safe and well tolerated. Concussions represent an ‘unmet’ medical...

read more

Odyssey Health, Inc. Announces Positive Results from Initial Phase I Clinical Trial Subjects for Concussion Drug

  IRVINE, CA, May 5, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, today announced positive results from the first group of patients dosed with PRV-002, in their Phase I clinical trial. Odyssey’s trial is administering PRV-002, their novel drug to treat concussion, to healthy human subjects. Thus far the drug has shown to be safe and well tolerated. Each year, there...

read more

Odyssey Health Welcomes United States Vice Admiral (r) Timothy Szymanski to Military Advisory Board

  IRVINE, CA, April 20, 2022 -- McapMediaWire -- Odyssey Health, Inc., formerly known as Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on developing a proprietary drug compound to treat concussion, is honored to welcome Vice Admiral (r) Timothy Szymanski to the Company’s prestigious Military Advisory Board. Odyssey’s drug candidate, PRV-002 is currently in a phase 1 clinical trial. “Too many service members and veterans are suffering...

read more

Odyssey Group International Announces Formation of Military Advisory Board and Welcomes Prestigious Members to Assist with Concussion Drug Development

  IRVINE, CA, March 31, 2022 -- McapMediaWire -- Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today announced the formation of its Military Advisory Board with the appointment of prestigious leaders in the field. Garnering experience and insight from these leaders in our military service branches will provide critical insight to traumatic brain injuries and the effects it has on those...

read more

Nutra Pharma Announces First Manufacturing Agreement

  Nutra Pharma is announcing Avini Health as its first contract manufacturing partner   Plantation, Florida, March 23, 2022 -- McapMediaWire -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, is announcing their first agreement to...

read more

Nutra Pharma Expands Manufacturing Capabilities

  Nutra Pharma is providing updates on their work in improving manufacturing scale and capabilities for new product launches for their OTC drugs and potential dietary supplements   Plantation, Florida, March 17, 2022 -- McapMediaWire -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple...

read more

Suggestion Box, Inc. (OTC:SGTB) Submits for Corporation Name Provides Shareholder Updates

  Prepares for Upcoming Merger and Plans for FINRA Name and Symbol Change   Las Vegas, Nevada, Feb. 17, 2022 -- McapMediaWire -- Suggestion Box (OTC Pink: SGTB) proudly announces it has filed for its new corporate name in the State of Texas. Tony D’Antonio, Chief Executive Officer, states “We are excited to move forward with the new corporate name of Feel Better Labs, Inc. which directly reflects the direction and operations of the incoming merging company and its product line. In...

read more

Software Effective Solutions Corporation Announces Acquisition of MedCana, Inc. and Appoints Jose Gabriel Diaz as New Chief Operating Officer and Director

    New Orleans, Louisiana, Feb. 07, 2022 -- McapMediaWire -- Software Effective Solutions Corporation (OTC Pink: SFWJ) (“the Company”) announces the Acquisition of MedCana, Inc and appoints Jose Gabriel Diaz as New Chief Operating Officer and Director Software Effective Solutions, Inc announces the acquisition of MedCana Inc. and positions the Company to become a leader in the Columbian Cannabis and CBD Oil Sectors. The Company also announces the appointment of Jose Gabriel Diaz to...

read more

PAOG Expects Increased Visibility For Its CBD Nutraceuticals From USMJ Ecommerce Campaign

  Sandusky, OH, Feb. 03, 2022 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to enjoy increased market visibility for its RX Branded CBD Nutraceuticals resulting from the kickoff of the USMJ Ecommerce expansion campaign announced earlier today. PAOG currently markets its own independent line of CBD nutraceutical products under its “RX” label available for sale on North American Cannabis Inc.’s (OTC Pink: USMJ) ecommerce site www.usmj.com. PAOG is...

read more

Gold River Productions, Inc. (GRPS) announces Production of New Product Inventory, Poised for Sales

  Palm Coast, FL, Feb. 02, 2022 -- McapMediaWire -- Gold River Productions, Inc. (OTC Pink: GRPS) announces the production of commercial inventory of Inflammaplex, Painplex, Energyplex and Longevityplex as part of its product line to enhance patient wellness and empower doctors with alternatives to toxic pharmaceuticals.  GRPS expects the products to be available in the spring, given the manufacturing cycle. “We’ve been working on this for a number of years,” says Dr. Bruce Bond, head of...

read more

PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development

  Sandusky, OH, Feb. 01, 2022  -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today republished its 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development strategy.  The update was originally released on Friday, January 27th, 2022. The update is included in its entirety below: PAO Group, Inc. is an emerging cannabis and CBD company targeting growth via two tracks – pharmaceutical and nutraceutical. The Company is developing a cannabis extract-based...

read more

PAOG Publishes 2022 Strategic Update

  Sandusky, OH, Jan. 28, 2022 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today released a 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development strategy. The update is included in its entirety below: PAO Group, Inc. is an emerging cannabis and CBD company targeting growth via two tracks – pharmaceutical and nutraceutical. The Company is developing a cannabis extract-based therapy to treat various respiratory diseases and illnesses including...

read more

PAOG Cites Research On Hemp Compounds Effectiveness Treating Covid To Advance Pharmaceutical Development

  Sandusky, OH, Jan. 25, 2022 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today cited recently published information on research indicating CBDA and CBGA, compounds found in hemp, “block a critical step in the process the [Covid] virus uses to infect people” (source). “The two compounds were identified during a chemical screening by researchers at the Linus Pauling Institute at Oregon State University. The compounds bind to spike proteins found on the virus and blocked the spike...

read more

PURA Aims To Modestly Extract $10 Million This Year From $18 Billion Hemp Industry Establishing A Foothold In A Much Larger Opportunity

Dallas, TX, Jan. 18, 2022 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today published a 2022 strategic management overview of the company’s plan for an anticipated $1 million in revenue with the potential to reach $10 million in revenue this year. The overview published today will be followed up over the next several weeks with additional management presentations covering more detail on each of the major overview components highlighted in the presentation below: Driving Demand For The...

read more

Nutra Pharma Letter to Shareholders

  Nutra Pharma has published their annual letter to shareholders to the Company’s website   Plantation, Florida, Jan. 18, 2022 -- McapMediaWire -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that the Company's...

read more

SIBANNAC, INC. AND SPUR BIOTECH, LLC ENTER LETTER OF INTENT TO MARKET PLANT BASED VACCINE

  Scottsdale, Arizona, Jan. 18, 2022  -- McapMediaWire -- Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following: The Company is proud to announce the entry into a Letter of Intent with SPUR Biotech, LLC (“SPUR”), an Ohio-based developer of plant-based vaccines. SPUR is a biotechnology company developing plant-based vaccines using Controlled Environment Agriculture (CEA) to sustainably grow leafy greens and biopharmaceuticals.  The vaccine under...

read more

PURA Targets $10 Million In 2022 Revenue From New Farmersville Hemp Business

Dallas, Texas, Jan. 12, 2022  -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today announced the company will publish a strategic overview presentation next week on Tuesday, January 18th covering the company’s 2022 plan to achieve a forecasted $1 million in revenue and reach for a potential $10 million in revenue.  The presentation will include the latest on PURA’s backing from UC Asset LP (OTCQX: UCASU) to construct the Farmersville Hemp Brand facility central to PURA’s updated business...

read more

Odyssey Group International Receives Donation to Support a Treatment for Concussion and forms Community Partnership with the Erase PTSD Now Foundation

  IRVINE, CA, Jan. 10, 2022 -- McapMediaWire -- Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today announced that it has received a donation in the amount of $500,000 in partnership with the Erase PTSD Now organization and the Glenn Greenberg and Linda Vester Foundation. These funds will be used to progress the Phase 1 human clinical trials for drug candidate PRV-002 for the treatment...

read more

PHBI – Pharmagreen Announces Affirmed MOU To Acquire Licensed California Cannabis Company

  CARSON CITY, NV, Jan. 06, 2022 -- McapMediaWire -- Pharmagreen Biotech, Inc., (OTCQB: PHBI), today announced an affirmed  memorandum  of understanding  (MOU)  to  acquire  Long  Valley Farms LLC, a California based cannabis company. The acquisition includes land, infrastructure, and a Cannabis cultivation license for the operation of a cannabis business in the State of California. This acquisition is a strategic component of Pharmagreen’s strategy to convert the revenue potential of its...

read more

PURA Farmersville Hemp Brand Set For Growth As Institutional Investment Portfolios Expand Hemp Positions

Dallas, TX, Dec. 29, 2021  -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today highlighted the recent Bloomberg article reporting on the investment outlook for the hemp market in 2022. Hemp Is Ready to Shine, Thanks to Plastic Bans and Carbon Caps Article highlights include: “Demand is poised to rise for hemp — the staid sister to the mood-altering forms of cannabis — as it’s increasingly adopted for a wide range of uses, including concrete blocks, clothing and even car parts. The shift...

read more

PURA Revenue Model Comes Into Focus As Company Pursues $18 Billion Hemp Market

Dallas, Texas, Dec. 16, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today confirmed a 2022 $1 million revenue forecast for its hemp business with a revenue upside potential to $10 million by year end 2022. PURA is targeting the industrial hemp market with a cooperative branding strategy founded largely on hemp’s potential sustainability impact. PURA has established a new business model to build an industrial hemp business with 3 sources of revenue – education, branding and...

read more

PAOG Recommends Its RelaxRX Full Spectrum CBD To Ease Stress Before Fed Decision

    Sandusky, OH, Dec. 15, 2021 -- McapMediaWire --  PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s line of “RX” branded full-spectrum CBD products are now available for sale at www.usmj.com. PAOG is developing both pharmaceutical and nutraceutical treatments based on its own proprietary extraction technology. The RX branded products are PAOG’s first nutraceutical products. The RX branded products have been well received and are now available for sale direct to...

read more

PURA Sustainable Farmersville Hemp Brand Bolstered By USASU $0.10-0.15 Net Profit Per Share Projection

  Dallas, TX, Dec. 10, 2021 -- McapMediaWire - Puration, Inc. (OTC Pink: PURA) today highlighted the strength of its cannabis real estate finance partner, UC Asset LP (OTCQX: UCASU). UCASU has announced a projected $0.10 to $0.15 net profit per share to be reported for year end 2021.  UCASU is financing the construction of PURA’s hemp university facility in Farmersville, Texas and has agreed to back PURA Farmersville Hemp Brand Partners cannabis real estate projects. PURA is targeting the...

read more

PURA and PAOG Announce CBD IP Deal In Conjunction With New CBD Infused Product Developments

  Sandusky, OH, Dec. 03, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) announced the closing of a transaction today whereby PAOG has acquired an exclusive license to a patented cannabis extraction process from PURA that will expand PAOG’s existing CBD intellectual property. Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). ...

read more

PURA and PAOG Confirm CBD IP Deal Schedule To Close Friday

  Sandusky, OH, Dec. 01, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) today confirmed the companies have finalized terms for PAOG to acquire an exclusive license to a patented cannabis extraction process from PURA that will expand the PAOG’s existing CBD intellectual property. Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No....

read more

Categories

Mcap MediaWire - Costumer Service

Translate »